Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurological disorders
Pharma
Neurocrine's Ingrezza misses in cerebral palsy trial
Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure.
Angus Liu
Dec 23, 2025 10:20am
What's on neurologists' minds? Not drug names, survey shows
Jul 18, 2025 10:10am
BMS' schizophrenia drug stumbles in blow to blockbuster plan
Apr 23, 2025 10:35am
Neurology patients call out pharma for inadequate investment
Nov 19, 2024 11:20am
Neurocrine elevates BD chief to succeed founder and CEO
May 29, 2024 11:42am
Neurocrine joins in on Tardive Dyskinesia Awareness Week
May 6, 2024 10:52am
